Migraine treatment

May 20, 2025

Incyte’s ZYNYZ Approved as First-Line Treatment for Advanced Anal Cancer; Amneal Gets FDA Nod for BREKIYA for Migraines; FDA Accepts Travere’s sNDA for FILSPARI in FSGS; AbbVie’s EMRELIS Approved for Advanced NSCLC With High c-Met; Merck’s WELIREG Approved for Advanced PPGL in Patients 12+

Jun 09, 2021

Migraine Market: How Pharma Companies are trying to Uncomplicate the Disease and Bring in Novel Therapies

Oct 07, 2019

A New Era for Migraine Treatment and CGRP antibodies

Newsletter/Whitepaper